The results revealed that significantly higher CREB3L1 expression was observed in 7 cancer types than their corresponding adjacent non-cancerous tissues, including breast invasive carcinoma (BRCA), cholangiocarcinoma (CHOL), kidney chromophobe (KICH), liver hepatocellular carcinoma (LIHC), pancreatic adenocarcinoma (PAAD), prostate adenocarcinoma (PRAD) and stomach adenocarcinoma (STAD). Here, CREB3L1 is linked to pancreatic adenocarcinoma.